The Formin, DIAPH1, is a Key Modulator of Myocardial Ischemia/Reperfusion Injury.
The Formin, DIAPH1, is a Key Modulator of Myocardial Ischemia/Reperfusion Injury.
复制标题
DOI:
10.1016/j.ebiom.2017.11.012
复制
发表时间:
2017-12
期刊:
影响因子:
11.1
通讯作者:
Ramasamy R
中科院分区:
文献类型:
--
作者:
O'Shea KM;Ananthakrishnan R;Li Q;Quadri N;Thiagarajan D;Sreejit G;Wang L;Zirpoli H;Aranda JF;Alberts AS;Schmidt AM;Ramasamy R
The biochemical, ionic, and signaling changes that occur within cardiomyocytes subjected to ischemia are exacerbated by reperfusion; however, the precise mechanisms mediating myocardial ischemia/reperfusion (I/R) injury have not been fully elucidated. The receptor for advanced glycation end-products (RAGE) regulates the cellular response to cardiac tissue damage in I/R, an effect potentially mediated by the binding of the RAGE cytoplasmic domain to the diaphanous-related formin, DIAPH1. The aim of this study was to investigate the role of DIAPH1 in the physiological response to experimental myocardial I/R in mice. After subjecting wild-type mice to experimental I/R, myocardial DIAPH1 expression was increased, an effect that was echoed following hypoxia/reoxygenation (H/R) in H9C2 and AC16 cells. Further, compared to wild-type mice, genetic deletion of Diaph1 reduced infarct size and improved contractile function after I/R. Silencing Diaph1 in H9C2 cells subjected to H/R downregulated actin polymerization and serum response factor-regulated gene expression. Importantly, these changes led to increased expression of sarcoplasmic reticulum Ca2 + ATPase and reduced expression of the sodium calcium exchanger. This work demonstrates that DIAPH1 is required for the myocardial response to I/R, and that targeting DIAPH1 may represent an adjunctive approach for myocardial salvage after acute infarction. DIAPH1 is a key mediator of ischemia/reperfusion injury in the heart. Diaph1 deletion regulates the transcription factor, serum response factor, leading to modulation of calcium transporters in cardiomyocytes. The effects of Diaph1 deletion are associated with improved contractile function after short-term ischemia/reperfusion injury, making it a potential adjunctive therapeutic target for treatment of evolving myocardial infarction. Although reperfusion therapy, using thrombolytic agents, has become the mainstay for the treatment of patients with myocardial infarction, benefits of this therapy are reduced by multiple factors including reperfusion injury. The precise mechanisms for this effect are yet to be fully delineated. In this study we identify the formin DIAPH1 as a novel mediator of ischemia/reperfusion (I/R) injury in the heart. We show that Diaph1 deletion regulates the transcription factor, serum response factor, leading to modulation of calcium transporters in cardiomyocytes. We show that deletion of Diaph1 improved contractile function after I/R in the mouse heart, making DIAPH1 a potential adjunctive therapeutic target for the treatment of evolving myocardial infarction.
登录
查看更多内容
影响因子:
37.8
作者:
MILLER, TD;CHRISTIAN, TF;GIBBONS, RJ
通讯作者:
GIBBONS, RJ
影响因子:
37.8
作者:
PFEFFER, MA;BRAUNWALD, E
通讯作者:
BRAUNWALD, E
影响因子:
5
作者:
Kimura, Tomomi E.;Duggirala, Aparna;Hindmarch, Charles C. T.;Hewer, Richard C.;Cui, Mei-Zhen;Newby, Andrew C.;Bond, Mark
通讯作者:
Bond, Mark
DOI:
10.1152/ajpheart.00397.2003
发表时间:
2004-10-01
影响因子:
4.8
作者:
Bölck, B;Münch, G;Schwinger, RHG
通讯作者:
Schwinger, RHG
影响因子:
4.8
作者:
Mack, CP;Somlyo, AV;Owens, GK
通讯作者:
Owens, GK